https://www.cnbc.com/2023/12/06/abbvie-to-acquire-cerevel-therapeutics-for-8point7-billion-.html
0
0
12/6/23 at 10:06pm
Organization
CNBC
Author
Annika Kim Constantino
35 words
0
Comments
The deal is AbbVie's latest attempt to expand its drug pipeline as its top-selling treatments, such as Humira, face generic competition.
1 similar article
You are the first to view
Create an account
or login to join the discussion